Fauci apologizes for casting doubt over UK's approval of Pfizer vaccine

"I do have great faith in both the scientific community and the regulatory community in the UK," Fauci said

Anthony Fauci
“I did not mean to apply any sloppiness (to the UK regulatory process) even though it came out that way,” he said
Reuters London
1 min read Last Updated : Dec 05 2020 | 1:28 AM IST
Anthony Fauci, the top U.S. infectious diseases expert, apologized on Thursday after casting doubt over the rigor of the British regulators who approved the Pfizer vaccine against Covid-19 and said he had faith in their work.

“There really has been a misunderstanding, and for that I’m sorry, and I apologize for that,” Fauci said in an interview with BBC television, after his earlier comments on CBS were broadcast in Britain and received prominent coverage.

“I do have great faith in both the scientific community and the regulatory community in the UK,” Fauci said.

“I did not mean to apply any sloppiness (to the UK regulatory process) even though it came out that way,” he said. “So if it did, I just want to set the record straight. I have a great deal of confidence in what the UK does both scientifically and from a regulatory standpoint.”

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :UKCoronavirus VaccinePfizer

Next Story